翰思艾泰-B

03378
22.6603.82% ( -0.900 )
延遲 已收盤: 11月20日 16:08:00

股東

全部股東

股東類型

  • 私人企業79.49%
  • 公眾及其他12.05%
  • 上市公司4.72%
  • 機構投資者2.32%
  • 個人與內幕人士1.43%

主要股東

主要股東 最新
股東
Cai Zhang Biotechnology (Hangzhou) Co., Ltd
40.60%5,530.00 萬0.00%+031/12/2025
Hanx Biopharmaceuticals (HK) Limited
13.06%1,779.36 萬0.00%+031/12/2025
Hangzhou Hongye Ruiji Investment Partnership (Limited Partnership)
9.44%1,286.05 萬0.00%+0
Beijing Lapam Biopharmaceutical Venture Capital Center (Limited Partnership)
9.44%1,286.05 萬0.00%+0
Betta Pharmaceuticals Co., Ltd.
4.72%643.02 萬0.00%+023/12/2025
Wuhan Donggaorensi Equity Investment Partnership (Limited Partnership)
2.51%341.61 萬0.00%+023/12/2025
Wuhan Hanx Tai Management Consulting Partnership (L.P.)
2.24%304.51 萬0.00%+031/12/2025
Hangzhou Tailong Venture Capital Partnership Enterprise (L.P.)
1.88%256.21 萬0.00%+023/12/2025
Yangtze Investment (HK) Limited
1.32%180.40 萬0.00%+023/12/2025
Qixiang LiCEO, CSO, GM & Executive Director
1.00%136.64 萬0.00%+031/12/2025
Tibet Lapam Small and Medium Enterprise Development Fund Equity Investment Partnership (Limited Part
0.88%119.56 萬0.00%+0
Lapam Capital
0.44%59.60 萬0.00%+0
Min LiuCOO, Vice GM & Executive Director
0.40%54.66 萬0.00%+031/12/2025
Liao Tong
0.02%2.14 萬0.00%+023/12/2025
Jieyu XiaoCFO, Secretary of the Board & Executive Director
<0.01%1.11 萬0.00%+031/12/2025
Zou Zhiyong
<0.01%1,710.000.00%+023/12/2025